Stay updated on Interchangeability Study of ABP 654 in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Interchangeability Study of ABP 654 in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Interchangeability Study of ABP 654 in Psoriasis Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has expanded to include 88 locations and has been updated to revision v2.10.0, replacing the previous revision v2.9.7.
    Difference
    0.2%
    Check dated 2024-07-23T15:47:39.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.0%
    Check dated 2024-07-16T10:06:37.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.
    Difference
    0.0%
    Check dated 2024-07-02T17:31:26.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content related to the study details of a clinical trial investigating the interchangeability of ABP 654 for the treatment of participants with moderate to severe plaque psoriasis.
    Difference
    0.0%
    Check dated 2024-06-27T12:46:36.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.
    Difference
    0.0%
    Check dated 2024-06-26T11:08:29.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Show more Show more Revision: v2.9.0' has been updated to 'Show less MedlinePlus related topics: Psoriasis Drug Information available for: Ustekinumab FDA Drug and Device Resources Show less Design Details Primary Purpose : Treatment Allocation : Randomized Interventional Model : Parallel Assignment Masking : Double ( Participant Investigator ) Masking Description: The investigators, study personnel (with the exception of the Data Monitoring Committee (DMC), and unblinded Parexel staff supporting DMC activities and randomization list activities) and the study participants will remain blinded to treatment allocation.' This change reflects an update in the information displayed on the webpage.
    Difference
    58%
    Check dated 2024-06-25T10:10:24.000Z thumbnail image

Stay in the know with updates to Interchangeability Study of ABP 654 in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Interchangeability Study of ABP 654 in Psoriasis Clinical Trial page.